Pernix to Enhance Drug-Making Ability with Acquisition
July 6, 2012- Share:
Pernix Therapeutics (NYSE: PTX), a pharmaceutical company that received development from OrbiMed Advisors and Aisling Capital in 2011, has agreed to acquire pharmaceutical contract manufacturing company Great Southern Laboratories for $4.9 million. The deal, which is expected to close in July 2012, includes Great Southern Laboratories’ manufacturing facilities in Houston. Pernix anticipates accelerated product development and improved gross margins following the transaction.
Pharmaceuticals
Houston, TX
Investor
- Share:
-
-
-
-